TiumBio cuts 2023 stock option grant to 124,000 shares after employee departures

• TiumBio corrected its March 29, 2023 stock option grant disclosure to reflect cancellations tied to employee departures.
• Recipients cut to 13 from 14; granted shares reduced to 124,000 from 127,000.
• Total stock options outstanding after the grant revised to 1,041,988 shares from 1,017,488.
• Terms unchanged: exercise price KRW 9,810; exercise window runs from March 29, 2025 to March 28, 2030.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TiumBio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000238), on September 30, 2026, and is solely responsible for the information contained therein.